A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study. [electronic resource]
Producer: 20190314Description: 305 p. digitalISSN:- 1745-6215
- Aged
- Anti-Bacterial Agents -- administration & dosage
- Bacteremia -- diagnosis
- Cause of Death
- Daptomycin -- administration & dosage
- Drug Resistance, Bacterial
- Early Termination of Clinical Trials
- Female
- Humans
- Male
- Methicillin-Resistant Staphylococcus aureus -- drug effects
- Microbial Sensitivity Tests
- Middle Aged
- Predictive Value of Tests
- Recurrence
- Singapore
- Staphylococcal Infections -- diagnosis
- Time Factors
- Treatment Outcome
- Vancomycin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.